Masthead.
- Published in:
- Clinical Cardiology, 1997, v. 20, n. S1, p. fmi, doi. 10.1002/clc.4960201301
- Publication type:
- Article
Works matching IS 01609289 AND DT 1997 AND VI 20 AND IP S1
Results: 9
1
2
Perflenapent emulsion (echogen®): A new long-acting phase-shift agent for contrast echocardiography.
- Published in:
- Clinical Cardiology, 1997, v. 20, n. S1, p. 12, doi. 10.1002/clc.4960201305
- By:
- Publication type:
- Article
3
Impact of contrast echocardiography on diagnostic algorithms: Pharmacoeconomic implications.
- Published in:
- Clinical Cardiology, 1997, v. 20, n. S1, p. 39, doi. 10.1002/clc.4960201309
- By:
- Publication type:
- Article
4
History of echocardiographic contrast agents.
- Published in:
- Clinical Cardiology, 1997, v. 20, n. S1, p. 7, doi. 10.1002/clc.4960201304
- By:
- Publication type:
- Article
5
Current role of contrast echocardiography in the diagnosis of cardiovascular diseases.
- Published in:
- Clinical Cardiology, 1997, v. 20, n. S1, p. 31, doi. 10.1002/clc.4960201308
- By:
- Publication type:
- Article
6
The emerging role of contrast agents in echocardiography.
- Published in:
- Clinical Cardiology, 1997, v. 20, n. S1, p. 3, doi. 10.1002/clc.4960201303
- By:
- Publication type:
- Article
7
New developments in ultrasound systems for contrast echocardiography.
- Published in:
- Clinical Cardiology, 1997, v. 20, n. S1, p. 27, doi. 10.1002/clc.4960201307
- By:
- Publication type:
- Article
8
A new generation of ultrasound contrast agents for echocardiography.
- Published in:
- Clinical Cardiology, 1997, v. 20, n. S1, p. 1, doi. 10.1002/clc.4960201302
- By:
- Publication type:
- Article
9
Safety assessment of the use of perflenapent emulsion for contrast enhancement of echocardiography and diagnostic radiology ultrasound studies.
- Published in:
- Clinical Cardiology, 1997, v. 20, n. S1, p. 19, doi. 10.1002/clc.4960201306
- By:
- Publication type:
- Article